Clearmind Medicine, Inc. (CMND)
0.079
+0.01
(+10.18%)
USD |
NASDAQ |
Dec 12, 10:54
Clearmind Medicine EPS Diluted (Quarterly): -0.2459 for July 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.2491 |
| Lexaria Bioscience Corp. | -0.1378 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.314M |
| Total Expenses (Quarterly) | 1.314M |
| Enterprise Value | 0.8334M |
| Earnings Yield | -1.07K% |
| Normalized Earnings Yield | -1325.95 |